http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2002115959-A1

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F9-0008
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-30
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-007
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-30
filingDate 2002-04-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cbb41bf6c21d2b03e0de3e89a9898223
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2552ca97dc74113c99c91b6854f96617
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3edde9ba7671cf3ac4b1613723930cac
publicationDate 2002-08-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2002115959-A1
titleOfInvention Ocular iontophoretic device and method for inhibiting vascular endothelial growth factor (VEGF) using the same
abstract An ocular iontophoretic device for delivering an aptamer to an affected area of a living being's eye for inhibiting VEGF function therein, the device comprising an active electrode assembly associated with a matrix and/or reservoir, wherein the matrix and/or reservoir includes an aptamer capable of inhibiting VEGF function. n A method for treating an affected area of a living being's eye, comprising the steps of: associating an aptamer with an ocular iontophoretic device; positioning at least a portion of an ocular iontophoretic device on the eye of the living being; and iontophoretically delivering the aptamer to an affected area of the living being's eye.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8454582-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006110428-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006072887-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011038937-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007299386-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007299420-A1
priorityDate 2001-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID558154
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226460803
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP67860
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCH0ZCS4
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ99PS1
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP15691
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12325868
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP83906
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID403802
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226416533
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9MYV3
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID281572
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCC0K3N4
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID7422
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ00731
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP67964
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP49151
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID395909
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID22339
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129225113
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9GKR0
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP15692
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCC0K3N5
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID30682
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCA0A3Q2TVI4
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5391
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP16612
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP67965
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCF6QDM7
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID83785
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP50412
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP26617

Total number of triples: 53.